N/A
Completed N=22
Mindful After Cancer: A Mindfulness-based Therapy Intervention for Sexual Health After Cancer
Source: ClinicalTrials.gov NCT04559854 ↗Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcomePrimary: Feasibility/ Enrollment in the Study — 78.6 Percentage enrolled of eligible
Summary
The objectives of this study are to: 1) adapt a mindfulness-based therapy program designed to help women manage their sexual and body image concerns after cancer (Mindful After Cancer, MAC) to a videoconference format and 2) assess the feasibility, acceptability, and preliminary effects of the program among breast and gynecologic cancer survivors.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility/ Enrollment in the Study |
78.6 | — |
| PRIMARY Feasibility/ Retention in the Study |
22 | — |
| PRIMARY Feasibility/ Retention in the Intervention |
18 | — |
| PRIMARY Acceptability of the Intervention |
75.5 | — |
| SECONDARY Change From Baseline Interest in Sexual Activity at 1 Month |
4.4; 5.0 | — |
| SECONDARY Change From Baseline Satisfaction With Sex Life at 1 Month |
35; 37.3 | — |
| SECONDARY Change From Baseline Self-efficacy at 1 Month |
0.06 | — |
| SECONDARY Change From Baseline Body Image at 1 Month |
15.2; 13.1 | — |
| SECONDARY Change From Baseline Body Appreciation at 1 Month |
3.2; 3.6 | — |
| SECONDARY Change From Baseline Anxiety at 1 Month |
15.0; 12.9 | — |
| SECONDARY Change From Baseline Depression at 1 Month |
16.3; 13.9 | — |
| SECONDARY Change in Facets of Baseline Mindfulness at 1 Month |
10.8; 9.6; 9.3; 10.8; 9.7; 8.9 | — |
| SECONDARY Change From Baseline Self-compassion at 1 Month |
3.0; 2.9 | — |
| SECONDARY Change From Baseline Relationship Quality at 1 Month |
24.0; 25.3 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of breast or gynecologic cancer at least one year prior to enrollment
- Completed primary cancer treatment
- English speaking
- Have access to a computer, smart phone, or tablet with internet access
- Ability to spend 15-30 minutes per day on program activities
Exclusion Criteria
- Stage 0 (carcinoma in situ)
Data sourced from ClinicalTrials.gov (NCT04559854). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.